2018 Q4 Form 10-Q Financial Statement

#000114420418064695 Filed on December 14, 2018

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2018 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.820M $1.610M $1.840M
YoY Change -17.27% -31.49% -39.87%
% of Gross Profit
Research & Development $1.309M $929.9K $7.060M
YoY Change -61.64% -78.43% 128.48%
% of Gross Profit
Depreciation & Amortization $10.00K $25.37K $260.0K
YoY Change -96.25% -90.49% -7.14%
% of Gross Profit
Operating Expenses $1.309M $2.562M $8.950M
YoY Change -77.24% -61.86% 43.89%
Operating Profit -$3.161M -$2.562M
YoY Change -45.04% -61.86%
Interest Expense $1.287M $911.6K -$620.0K
YoY Change 875349.66%
% of Operating Profit
Other Income/Expense, Net -$1.000M -$803.2K $40.00K
YoY Change -3190.68% -2570.1% 33.33%
Pretax Income -$4.160M -$3.370M -$12.49M
YoY Change -27.27% -49.55% 101.78%
Income Tax
% Of Pretax Income
Net Earnings -$4.161M -$3.365M -$12.49M
YoY Change -27.23% -49.66% 101.78%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$3.328M -$2.718M -$10.07M
COMMON SHARES
Basic Shares Outstanding 62.17M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q4 2018 Q3 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $260.0K $400.0K $1.650M
YoY Change -70.11% -90.05% -63.25%
Cash & Equivalents $260.0K $400.0K $1.650M
Short-Term Investments
Other Short-Term Assets $91.55K $372.1K $361.9K
YoY Change -69.04% 6.32% -18.12%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $422.3K $773.0K $2.008M
YoY Change -63.72% -82.27% -59.26%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $178.7K $368.4K
YoY Change -100.0% -96.47% -93.08%
Goodwill
YoY Change
Intangibles $33.38K $35.21K $37.03K
YoY Change -17.93% -16.45%
Long-Term Investments
YoY Change
Other Assets $0.00 $80.00K $90.00K
YoY Change -100.0% -75.0% -72.73%
Total Long-Term Assets $33.38K $296.2K $495.1K
YoY Change -99.35% -94.56% -91.31%
TOTAL ASSETS
Total Short-Term Assets $422.3K $773.0K $2.008M
Total Long-Term Assets $33.38K $296.2K $495.1K
Total Assets $455.7K $1.069M $2.503M
YoY Change -92.79% -89.09% -76.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.090M $1.790M $1.710M
YoY Change -1.42% 14.01% 3.64%
Accrued Expenses $880.0K $1.230M $920.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $10.00K $4.140M $3.430M
YoY Change 0.0% 41300.0% 34200.0%
Long-Term Debt Due $10.00K
YoY Change
Total Short-Term Liabilities $2.976M $7.339M $6.248M
YoY Change 32.22% 334.27% 252.73%
LONG-TERM LIABILITIES
Long-Term Debt $5.006M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $148.2K $215.6K
YoY Change -100.0% -50.59% -29.21%
Total Long-Term Liabilities $5.006M $173.3K $215.6K
YoY Change 1762.74% -42.24% -34.58%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.976M $7.339M $6.248M
Total Long-Term Liabilities $5.006M $173.3K $215.6K
Total Liabilities $10.24M $7.512M $6.464M
YoY Change 306.54% 277.51% 207.65%
SHAREHOLDERS EQUITY
Retained Earnings -$101.7M -$97.55M -$94.18M
YoY Change 32.56% 46.43%
Common Stock $61.87K $62.17K $62.17K
YoY Change 26.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$9.788M -$6.443M -$3.961M
YoY Change
Total Liabilities & Shareholders Equity $455.7K $1.069M $2.503M
YoY Change -92.79% -89.09% -76.45%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2018 Q2
OPERATING ACTIVITIES
Net Income -$4.161M -$3.365M -$12.49M
YoY Change -27.23% -49.66% 101.78%
Depreciation, Depletion And Amortization $10.00K $25.37K $260.0K
YoY Change -96.25% -90.49% -7.14%
Cash From Operating Activities -$1.650M -$1.432M -$3.880M
YoY Change -47.45% -70.8% 6.59%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $10.00K $190.0K $1.550M
YoY Change 7650.0%
Cash From Investing Activities $10.00K $187.1K $1.550M
YoY Change -3317.66% -1822.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.500M $0.00 3.900M
YoY Change -100.0% 3.45%
NET CHANGE
Cash From Operating Activities -1.650M -$1.432M -3.880M
Cash From Investing Activities 10.00K $187.1K 1.550M
Cash From Financing Activities 1.500M $0.00 3.900M
Net Change In Cash -140.0K -$1.245M 1.570M
YoY Change -95.54% 164.43% 3825.0%
FREE CASH FLOW
Cash From Operating Activities -$1.650M -$1.432M -$3.880M
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$1.650M -$1.432M -$3.880M
YoY Change -47.45% -70.74% 9.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2014Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
28939 USD
CY2018Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001509261
CY2018Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2018Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2018Q3 dei Trading Symbol
TradingSymbol
RZLT
CY2018Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
62166309 shares
CY2018Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2018Q3 dei Document Type
DocumentType
10-Q
CY2018Q3 dei Amendment Flag
AmendmentFlag
false
CY2018Q3 dei Document Period End Date
DocumentPeriodEndDate
2018-09-30
CY2018Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2018Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2018Q3 dei Entity Registrant Name
EntityRegistrantName
Rezolute, Inc.
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
62166309 shares
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
52887981 shares
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-3960755 USD
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
877951 USD
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
4856 USD
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M18D
CY2018 rzlt Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Option Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionOutstandingWeightedAverageRemainingContractualTerm
P3Y4M24D
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
148224 USD
CY2018Q2 us-gaap Assets Current
AssetsCurrent
2007787 USD
CY2018Q2 us-gaap Other Assets Current
OtherAssetsCurrent
361915 USD
CY2018Q3 us-gaap Other Assets Current
OtherAssetsCurrent
372114 USD
CY2018Q2 us-gaap Cash
Cash
1645872 USD
CY2018Q3 us-gaap Cash
Cash
400871 USD
CY2018Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3434611 USD
CY2018Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1706154 USD
CY2018Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1788387 USD
CY2018Q2 us-gaap Assets
Assets
2502882 USD
CY2018Q3 us-gaap Assets
Assets
1069191 USD
CY2018Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
495095 USD
CY2018Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
296206 USD
CY2018Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
56841 USD
CY2018Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
56841 USD
CY2018Q2 us-gaap Deferred Costs Leasing Net Noncurrent
DeferredCostsLeasingNetNoncurrent
32850 USD
CY2018Q3 us-gaap Deferred Costs Leasing Net Noncurrent
DeferredCostsLeasingNetNoncurrent
25439 USD
CY2018Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
37030 USD
CY2018Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
35207 USD
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
368374 USD
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
178719 USD
CY2018Q3 us-gaap Assets Current
AssetsCurrent
772985 USD
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2502882 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
-6443181 USD
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-94183738 USD
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-97548971 USD
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
90160815 USD
CY2018Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91043622 USD
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q2 us-gaap Liabilities
Liabilities
6463637 USD
CY2018Q3 us-gaap Liabilities
Liabilities
7512372 USD
CY2018Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
215623 USD
CY2018Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
173270 USD
CY2018Q2 us-gaap Deposits
Deposits
25046 USD
CY2018Q3 us-gaap Deposits
Deposits
25046 USD
CY2018Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
190577 USD
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6248014 USD
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7339102 USD
CY2018Q2 us-gaap Interest Payable Current
InterestPayableCurrent
148372 USD
CY2018Q3 us-gaap Interest Payable Current
InterestPayableCurrent
356996 USD
CY2018Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
113997 USD
CY2018Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
132922 USD
CY2018Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
4137232 USD
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
62168 USD
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
62168 USD
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
517787 USD
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
443843 USD
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
886161 USD
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
622562 USD
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1069191 USD
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62166309 shares
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62166309 shares
CY2018Q3 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div><div style="color: rgb(0, 0, 0); font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; text-align: justify;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts in the financial statements and the accompanying notes. Such estimates and assumptions impact, among others, the following: estimated useful lives and impairment of depreciable assets, the fair value of share-based payments and warrants, fair value of derivative instruments, management&#8217;s assessment of going concern, estimates of the probability and potential magnitude of contingent liabilities and the valuation allowance for deferred tax assets due to continuing and expected future operating losses. Actual results could differ from those estimates.</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62166309 shares
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62166309 shares
CY2018Q3 rzlt Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Option Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionOutstandingWeightedAverageRemainingContractualTerm
P3Y1M2D
CY2018Q3 rzlt Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non Vested Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedWeightedAverageExercisePrice
1.37
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
45650841 shares
CY2018Q3 rzlt Share Based Compensation Arrangements By Share Based Payment Award Options Expired In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpiredInPeriodWeightedAverageExercisePrice
0
CY2018Q3 rzlt Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Warrants Expired In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWarrantsExpiredInPeriod
0 shares
CY2018Q2 rzlt Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Non Vested Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonVestedWeightedAverageExercisePrice
1.37
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
45635217 shares
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y3M18D
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.89
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y8M12D
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.65
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
10901335 shares
CY2018Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.62
CY2018Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.52
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.55
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
18837479 shares
CY2018Q3 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
1702767 shares
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1125000 shares
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
19415246 shares
CY2018Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.2 pure
CY2017Q3 us-gaap Depreciation
Depreciation
266613 USD
CY2018Q3 us-gaap Depreciation
Depreciation
25368 USD
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-3365233 USD
CY2017Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
342 USD
CY2018Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
18904 USD
CY2017Q3 us-gaap Interest Expense
InterestExpense
0 USD
CY2018Q3 us-gaap Interest Expense
InterestExpense
911602 USD
CY2017Q3 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
31838 USD
CY2018Q3 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
89466 USD
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
337 USD
CY2018Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
28 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6717129 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2562029 USD
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
6717129 USD
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
2562029 USD
CY2017Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
327600 USD
CY2018Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
239340 USD
CY2017Q3 rzlt Investor Relations
InvestorRelations
59871 USD
CY2018Q3 rzlt Investor Relations
InvestorRelations
44013 USD
CY2017Q3 us-gaap Professional Fees
ProfessionalFees
223594 USD
CY2018Q3 us-gaap Professional Fees
ProfessionalFees
121923 USD
CY2017Q3 rzlt Compensation And Benefits For General And Administrative
CompensationAndBenefitsForGeneralAndAdministrative
1795427 USD
CY2018Q3 rzlt Compensation And Benefits For General And Administrative
CompensationAndBenefitsForGeneralAndAdministrative
1249696 USD
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4310637 USD
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
929909 USD
CY2017Q3 rzlt Facilities And Other Costs
FacilitiesAndOtherCosts
502657 USD
CY2018Q3 rzlt Facilities And Other Costs
FacilitiesAndOtherCosts
249698 USD
CY2017Q3 us-gaap Manufacturing Costs
ManufacturingCosts
426089 USD
CY2018Q3 us-gaap Manufacturing Costs
ManufacturingCosts
72932 USD
CY2017Q3 rzlt Consultants And Outside Costs
ConsultantsAndOutsideCosts
130361 USD
CY2018Q3 rzlt Consultants And Outside Costs
ConsultantsAndOutsideCosts
46705 USD
CY2017Q3 rzlt Compensation And Benefits For Research And Development
CompensationAndBenefitsForResearchAndDevelopment
1500864 USD
CY2018Q3 rzlt Compensation And Benefits For Research And Development
CompensationAndBenefitsForResearchAndDevelopment
557391 USD
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-803204 USD
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
32517 USD
CY2018Q3 us-gaap Interest Paid
InterestPaid
0 USD
CY2017Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2018Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2017Q3 us-gaap Cash
Cash
4015715 USD
CY2017Q2 us-gaap Cash
Cash
4486538 USD
CY2017Q3 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-470823 USD
CY2018Q3 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-1245001 USD
CY2017Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4440000 USD
CY2018Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
CY2017Q3 rzlt Repayments Of Capital Lease Payable
RepaymentsOfCapitalLeasePayable
0 USD
CY2018Q3 rzlt Repayments Of Capital Lease Payable
RepaymentsOfCapitalLeasePayable
0 USD
CY2017Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5816 USD
CY2018Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
187139 USD
CY2017Q3 us-gaap Payments For Proceeds From Other Deposits
PaymentsForProceedsFromOtherDeposits
0 USD
CY2018Q3 us-gaap Payments For Proceeds From Other Deposits
PaymentsForProceedsFromOtherDeposits
0 USD
CY2017Q3 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
5816 USD
CY2014Q2 rzlt Payments Of Monthly Lease Adjusted Annually Percentage
PaymentsOfMonthlyLeaseAdjustedAnnuallyPercentage
0.03 pure
CY2014Q2 rzlt Adjusted Triple Net Expense Of Lease Payments
AdjustedTripleNetExpenseOfLeasePayments
34381 USD
CY2014Q2 us-gaap Area Of Land
AreaOfLand
27000 sqft
CY2014Q2 us-gaap Security Deposit
SecurityDeposit
750000 USD
CY2014Q2 us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
562500 USD
CY2018Q3 us-gaap Area Of Land
AreaOfLand
4100 sqft
CY2018Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
868565 USD
CY2018Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
770976 USD
CY2018Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2017Q3 us-gaap Interest Paid
InterestPaid
0 USD
CY2018Q3 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
0 USD
CY2017Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4905007 USD
CY2018Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1432140 USD
CY2017Q3 rzlt Increase Decrease In Deferred Lease Liability
IncreaseDecreaseInDeferredLeaseLiability
-24975 USD
CY2018Q3 rzlt Increase Decrease In Deferred Lease Liability
IncreaseDecreaseInDeferredLeaseLiability
-23428 USD
CY2017Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 USD
CY2018Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
208624 USD
CY2017Q3 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-84636 USD
CY2018Q3 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
179822 USD
CY2017Q3 us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
-5731 USD
CY2018Q3 us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
-7411 USD
CY2017Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-92845 USD
CY2018Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
10199 USD
CY2017Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
342 USD
CY2018Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
18904 USD
CY2017Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1507699 USD
CY2018Q3 us-gaap Share Based Compensation
ShareBasedCompensation
877951 USD
CY2017Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1823 USD
CY2018Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1823 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-6684612 USD
CY2018Q3 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
55000 USD
CY2018Q2 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
73904 USD
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3365233 USD
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6684612 USD
CY2018Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
702621 USD
CY2018Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
22852 USD
CY2017Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2018Q3 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
187139 USD
CY2017Q3 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2018Q3 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
0 USD
CY2017Q3 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
60000 USD
CY2018Q3 rzlt Fair Value Inputs Probability Of Default1
FairValueInputsProbabilityOfDefault1
0.5 pure
CY2018Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
500000 USD
CY2018Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
700000 USD
CY2018Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
15000000 USD
CY2018Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
626797 USD
CY2018Q2 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
683737 USD
CY2018Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
545257 USD
CY2018Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
602193 USD
CY2018Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
15000000 USD
CY2018Q3 rzlt Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Warrants Issued To Private Placement
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWarrantsIssuedToPrivatePlacement
15624 shares
CY2018Q3 rzlt Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercise Price Warrants Issued To Private Placement
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisePriceWarrantsIssuedToPrivatePlacement
1.00
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1632120 USD
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2406492 USD
CY2018Q3 rzlt Warrant Expense
WarrantExpense
4856 USD
CY2017Q3 rzlt Warrant Expense
WarrantExpense
14847 USD
CY2018Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 USD
CY2017Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
4500000 USD
CY2018Q3 us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-weight:bold;display:inline;">Note 1 Nature of Operations</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">These financial statements represent the consolidated financial statements of Rezolute, Inc. (&#8220;Rezolute&#8221;), and its wholly owned operating subsidiary AntriaBio Delaware, Inc. (&#8220;Antria Delaware&#8221;). Rezolute and Antria Delaware are collectively referred to herein as the &#8220;Company&#8221;. The Company is a clinical stage biopharmaceutical company.</div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q3 rzlt Cumulative Earnings Defecit
CumulativeEarningsDefecit
6566117 USD
CY2018Q1 us-gaap Debt Instrument Convertible Terms Of Conversion Feature
DebtInstrumentConvertibleTermsOfConversionFeature
The notes contained an optional conversion feature in which if the Company raises $20 million then, at the investor&#8217;s option, the notes would convert into the financing at a 20% discount of the financing terms.
CY2018Q2 rzlt Warrant Exercise Price Description
WarrantExercisePriceDescription
The exercise price was set at 120% of the average closing price of the 10 trading days preceding July 1, 2019, or $0.52.
CY2018Q3 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
25000 USD
CY2017Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
USD
CY2018Q3 rzlt Relative Fair Value Of Warrants
RelativeFairValueOfWarrants
1821000 USD
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
347836 USD
CY2018Q3 rzlt Operating Leases Future Minimum Payments Due In Five Years Gross
OperatingLeasesFutureMinimumPaymentsDueInFiveYearsGross
-357279 USD
CY2018Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
22852 USD
CY2018Q3 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
1702767 shares
CY2018Q4 us-gaap Effect Of Exchange Rate On Cash
EffectOfExchangeRateOnCash
1500000 USD
CY2018Q1 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
500000 USD
CY2018Q3 rzlt Operating Leases Future Minimum Payments Remainder Of Fiscal Year Gross
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYearGross
-596155 USD
CY2018Q3 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Remainder Of Fiscal Year
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsRemainderOfFiscalYear
309246 USD
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
286909 USD
CY2018Q3 rzlt Operating Leases Future Minimum Payments Due In Two Years Gross
OperatingLeasesFutureMinimumPaymentsDueInTwoYearsGross
-688892 USD
CY2018Q3 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Within Two Years
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears
390076 USD
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
298816 USD
CY2018Q3 rzlt Operating Leases Future Minimum Payments Due In Three Years Gross
OperatingLeasesFutureMinimumPaymentsDueInThreeYearsGross
-338392 USD
CY2018Q3 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Within Three Years
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears
0 USD
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
338392 USD
CY2018Q3 rzlt Operating Leases Future Minimum Payments Due In Four Years Gross
OperatingLeasesFutureMinimumPaymentsDueInFourYearsGross
-347836 USD
CY2018Q3 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Within Four Years
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFourYears
0 USD
CY2018Q3 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Within Five Years
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFiveYears
0 USD
CY2018Q3 rzlt Operating Leases Future Minimum Payments Due Thereafter Gross
OperatingLeasesFutureMinimumPaymentsDueThereafterGross
-212085 USD
CY2018Q3 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Thereafter
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter
0 USD
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
212085 USD
CY2018Q3 rzlt Operating Leases Future Minimum Payments Due Gross
OperatingLeasesFutureMinimumPaymentsDueGross
-2540639 USD
CY2018Q3 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions
FutureMinimumSubleaseRentalsSaleLeasebackTransactions
699322 USD
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1841317 USD
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
357279 USD
CY2014Q2 us-gaap Security Deposit Liability
SecurityDepositLiability
187500 USD
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
8527967 USD
CY2017Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1507699 USD
CY2017Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
14847 USD
CY2017Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4440000 USD
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
7805901 USD
CY2018Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
5350000 USD
CY2018Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1212768 USD

Files In Submission

Name View Source Status
0001144204-18-064695-index-headers.html Edgar Link pending
0001144204-18-064695-index.html Edgar Link pending
0001144204-18-064695.txt Edgar Link pending
0001144204-18-064695-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rzlt-20180930.xml Edgar Link completed
rzlt-20180930.xsd Edgar Link pending
rzlt-20180930_cal.xml Edgar Link unprocessable
rzlt-20180930_def.xml Edgar Link unprocessable
rzlt-20180930_lab.xml Edgar Link unprocessable
rzlt-20180930_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending
tv506226_10q.htm Edgar Link pending
tv506226_ex31-1.htm Edgar Link pending
tv506226_ex31-2.htm Edgar Link pending
tv506226_ex32-1.htm Edgar Link pending
tv506226_ex32-2.htm Edgar Link pending